Latest Intelligence on General Business in Middle East and Africa

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Mecca Cola: singing a different tune

Mecca Cola is in direct competition with Coca-cola, deliberately appealing to anti-US sentiments. This growing tendency for manufacturers to market themselves on a political positioning to take advantage of consumer concerns creates a loyal customer base that will not be easily swayed.

Published By Datamonitor
09 Jan 2003
CommentWire
CommentWire

Money market funds: back in fashion

In the wake of large-scale outflows from money market funds late last year, Datamonitor argued that investors' fears around this fund class were unjustified, and predicted significant movements of cash back into the category. The latest data shows that we were right: money market funds are back in fashion, although they will have to fight for investors' attention during 2009.

Published By Datamonitor
29 Jan 2009
CommentWire
CommentWire

Nestle/Danone: a formula for bad news

Selling formula baby milk to mothers in developing nations to replace breast milk has long been a touchy issue. As consumers become ever more suspicious of the motives of big business, some companies have allegedly still not mended their ways, courting bad press every time they reappear in the headlines.

Published By Datamonitor
21 Jan 2003
CommentWire
CommentWire

Nitel: into foreign hands

The Nigerian government has handed over control of its notoriously inefficient and corrupt state-run telecom operator to a Dutch telecoms consultancy, with a view to a later IPO. The consultancy, Pentascope International, may have to ensure heavy investment in the network to meet its contractual obligations.

Published By Datamonitor
20 Mar 2003
CommentWire
CommentWire

Opec: rubbing its hands

The price of Brent crude futures has risen by $7 per barrel on the IPE in London since January, bringing calls for Opec to increase its output and prevent further rises. Those calls have been dismissed as premature, but the oil exporters' determination to control production may yet be tested in the coming months.

Published By Datamonitor
05 Apr 2002
Expert View
Expert View

Opportunity knocks for big pharmaceutical companies in the credit crunch

Although the credit crunch has left non-financial services companies, including those in the biotechnology industry, without cheap debt, the pharmaceutical industry avoided relying on this resource and has remained cash-rich. As a result, pharmaceutical companies should weather the financial storm and be able to make significant acquisitions, unlike their biotechnology counterparts.

Published By Datamonitor
09 Oct 2008
Expert View
Expert View

Organizations need to take a long-term approach to retention

Regulations in some industries dictate that data must be kept for long periods - potentially over 100 years, but many organizations do not consider long-term retention when archiving. However, if they do not take action now, when information has to be retrieved it may be unreadable, as the application that created it will certainly not exist, and the file format it was created in may be obsolete.

Published By Datamonitor
25 May 2007
CommentWire
CommentWire

Oxford GlycoSciences/Teva: identifying Israeli opportunities

The deal is important, since 10-15% of Gaucher disease patients live in Israel. While it goes against OGS' intended strategy of marketing Vevesca alone, the deviation will be beneficial in the long run. Israel will not be as strong a market for OGS' later compounds, and a large licensing payment at this stage will help it establish salesforces in the key pharma markets.

Published By Datamonitor
21 Nov 2001
Expert View
Expert View

Paper-based records have no in-built provision for disaster recovery

Even in the electronic age, there are still organizations that, despite using electronic systems to manage their information, still print all documents and records, and maintain the paper version as the official record. Apart from the time wasted in delivering paper records from off-site storage facilities back to the organization, there are inherent risks in maintaining paper-based records.

Published By Datamonitor
11 May 2007
CommentWire
CommentWire

Peptor: investigating additional indications in diabetes

DiaPep277 has already shown strong trial results for type I diabetes, which is in some ways similar to LADA. This makes the new investigation seem worthwhile. Approval would provide a new treatment option for an often-misdiagnosed subcategory of diabetic patients. It would also greatly increase the market potential of the drug, by allowing access to a much larger patient population.

Published By Datamonitor
15 Jan 2002

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.